Radiation in Patients With ALK-Positive Lung Cancer and Newly Diagnosed Brain Metastasis Receiving First-Line ALK Inhibitor
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
International Journal of Radiation Oncology, Biology, Physics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Real world use of radiation for newly diagnosed brain metastases in ALK-positive lung cancer receiving a first line ALK inhibitor
Int. J. Radiat. Oncol. Biol. Phys 2022 Jul 20;[EPub Ahead of Print], S Kumar, X Wang, H Pittell, GS Calip, SE Weiss, JE Meyer, TJ RoyceFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.